1. Home
  2. QNCX vs VSME Comparison

QNCX vs VSME Comparison

Compare QNCX & VSME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNCX
  • VSME
  • Stock Information
  • Founded
  • QNCX 2012
  • VSME 2013
  • Country
  • QNCX United States
  • VSME Hong Kong
  • Employees
  • QNCX N/A
  • VSME N/A
  • Industry
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • VSME
  • Sector
  • QNCX Health Care
  • VSME
  • Exchange
  • QNCX Nasdaq
  • VSME Nasdaq
  • Market Cap
  • QNCX 85.9M
  • VSME 99.9M
  • IPO Year
  • QNCX 2019
  • VSME 2023
  • Fundamental
  • Price
  • QNCX $1.60
  • VSME $2.73
  • Analyst Decision
  • QNCX Strong Buy
  • VSME
  • Analyst Count
  • QNCX 6
  • VSME 0
  • Target Price
  • QNCX $8.00
  • VSME N/A
  • AVG Volume (30 Days)
  • QNCX 124.9K
  • VSME 3.3M
  • Earning Date
  • QNCX 11-12-2025
  • VSME 04-14-2025
  • Dividend Yield
  • QNCX N/A
  • VSME N/A
  • EPS Growth
  • QNCX N/A
  • VSME N/A
  • EPS
  • QNCX N/A
  • VSME N/A
  • Revenue
  • QNCX N/A
  • VSME $8,248,108.00
  • Revenue This Year
  • QNCX N/A
  • VSME N/A
  • Revenue Next Year
  • QNCX N/A
  • VSME N/A
  • P/E Ratio
  • QNCX N/A
  • VSME N/A
  • Revenue Growth
  • QNCX N/A
  • VSME 3.22
  • 52 Week Low
  • QNCX $0.69
  • VSME $0.51
  • 52 Week High
  • QNCX $2.45
  • VSME $3.69
  • Technical
  • Relative Strength Index (RSI)
  • QNCX 47.89
  • VSME 83.65
  • Support Level
  • QNCX $1.56
  • VSME $2.32
  • Resistance Level
  • QNCX $1.65
  • VSME $2.80
  • Average True Range (ATR)
  • QNCX 0.07
  • VSME 0.31
  • MACD
  • QNCX 0.00
  • VSME 0.05
  • Stochastic Oscillator
  • QNCX 64.65
  • VSME 92.68

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

About VSME VS Media Holdings Limited

VS Media Holdings Ltd manages a network of digital Creators who create and publish content to social media platforms such as YouTube, Facebook, Instagram, and TikTok. Its Creators include influencers, KOLs-Key Opinion Leaders, bloggers, and other content creators who cultivate fan bases on social media platforms. The company's business provides value to two business stakeholders: Creators and Brands. The Value to Creators, that empowers and supports Creators by providing them with production facilities, training, and funding to produce quality content and the Value to Brands, where the company bridges the divide between Brands and Creators by helping Brands reach their target audience effectively by advising on content and budget and recommending specific Creators.

Share on Social Networks: